The Next Generation of Therapy for Chronic Insomnia

Chronic insomnia affects ~12% of adults

  • Incidence and prevalence are rising 1,2
  • Higher rates of insomnia in women, elderly, and those with underlying medical and psychiatric disorders 3

¹ de Entrambasaguas et al. Sleep Epidemiology. 2023 
² Reuben C, Elgaddal N, Black LI. National Center for Health Statistics. 2023. 
³ American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). 


Chronic Insomnia:

  • Impairs daytime alertness
  • Impairs quality of life
  • Increases risk of developing:
  • Hypertension
  • Obesity
  • Diabetes 
  • Infections
  • Increases risk of:
  • Motor vehicle accidents
  • Work-related injuries

Advantages of SOM001

  • Well tolerated 
  • Infrequent side effects
  • Not habit forming
  • No automatic sleep behaviors
  • Safe in long-term use
  • Improved adherence

info@somnumpharma.com

New York, NY. USA